3 ms·
You can't ask insurance to pay for it unless there is evidence of effectiveness. That requires trials and lots of time, and there is also the issue of heavy re
by rsj_hn 5y ago
You can't ask insurance to pay for it unless there is evidence of effectiveness. That requires trials and lots of time, and there is also the issue of heavy regulations and insane costs as soon as the word "treatment" is dropped into the mix. Then there is an extra hurdle for coverage of psychiatric treatments.
Assuming this is a real thing and not anecdata, expect ketamine to be covered in Europe long before it's covered in the U.S. Unfortunately our system is a huge mess and incredibly slow and expensive compared to Europe when it comes to approving new treatments.
- ghotli 5y agohttps://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified https://www.fda.gov/news-events/press-announcements/fda-appr... I think it might be further along than your comment suggests. "site:nih.gov esketamine" if you want to peruse what's been done
- rsj_hn 5y agoThanks for this info. Yes, this is farther along than I expected!
- goatsi 5y agoThat's only for one of the isomers of ketamine (rather than the mixture of two used in ketamine clinics), and only for using a nasal spray. That is because the drug company has a patent for using that specific isomer in a nasal spray. None of the esketamine research can be used as evidence for regular (off patent) ketamine. It will need it's own studies. https://qz.com/1889308/why-isnt-ketamine-approved-as-an-antidepressant/ https://qz.com/1889308/why-isnt-ketamine-approved-as-an-anti...